BUY CLAVULIN ONLINE

Description

CLAVULIN® AND CLAVULIN 12H® in all their presentations are indicated for the short-term treatment of pediatric patients with recurrent or persistent acute otitis media caused by Streptococcus pneumoniae resistant or not to penicillin (minimal inhibitory concentration (MIC) of penicillin ≤ 4 μg / mL), Haemophilus influenzae * and Moraxella catarrhalis *.

CLAVULIN® AND CLAVULIN 12H® is recommended for bacterial infections caused by microorganisms sensitive to CLAVULIN® AND CLAVULIN 12H® in the following sites:

– Infections of the upper respiratory tract (including ear, sinuses, nose and throat), eg. eg Recurrent tonsillitis, sinusitis, otitis media, typically caused by Streptococcus pneumoniae, Haemophilus influenzae *, Moraxella catarrhalis *, Staphylococcus aureus *, and Streptococcus pyogenes.

– Lower respiratory tract infections, eg. eg: acute and chronic bronchitis. Acute exacerbation of chronic bronchitis, lobar pneumonia, and bronchopneumonia, typically caused by Streptococcus pneumoniae, Haemophilus influenzae *, Staphylococcus aureus *, and Moraxella catarrhalis *.

– Genitourinary tract infections, p. eg: cystitis, urethritis, pyelonephritis and female genital infections typically caused by Enterobacteriaceae * (mainly Escherichia coli *), Staphylococcus saprophyticus, Enterococcus sp, and Neisseria gonorrhoeae *.

– Infections of the skin and soft tissues, typically caused by Staphylococcus aureus *, Streptococcus pyogenes and Bacteroides sp *.

– Dental infections such as uncomplicated gingivitis, necrotizing ulcerative gingivitis, acute, chronic or aggressive periodontitis, abscess of the periodontium (gingival, periodontal and pericorone) caused by bacteria such as: Peptoestreptococcus anaerobius, Fusobacterium nucleatum, Staphylococcus aurecous *, Staphylococcus aurecous *, Staphylococcus aurecous *, Staphylococcus aurecous * viscosus, Bacteroides melaninogenicus, Vellionella atypica, Actinobacillus sp, Treponema sp *, Prevotella intermedia and Selenomonas sputigena.

– Amoxicillin is recommended by the American Cardiology Association in a single dose (50 mg / kg / 1 h or 2 g as a maximum dose, orally), prior to a dental procedure in heart disease patients.

* SOME MEMBERS OF THESE SPECIES OF BACTERIA PRODUCE BETALACTAMASES, WHICH ARE NOT SENSITIVE TO AMOXICILLIN ALONE.